Taking A Bold Path To Improve Fibrosis Prognosis

Agomab Is Targeting Two Growth Factor Pathways Which Could Help To Modify Disease Outcomes

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.